 "Nifty Energy Index faces resistance at 44,325; traders advised to book profits, while Pharma Index suggests a cautious sell strategy.")
The Nifty Energy Index is currently experiencing a bullish trend but has hit a crucial resistance level at 44,325. Traders are advised to book profits and reduce long positions as profit booking is anticipated with any rise from this point. Support levels to watch are at 43,800, 43,600, and 43,200, making it ideal to wait ...
 "Aurobindo Pharma finalizes acquisition of GLS Pharma, enhancing its oncology portfolio, gaining full ownership by December 2024.")
Aurobindo Pharma Ltd has announced its plan to acquire the remaining 49 percent stake in GLS Pharma Ltd for Rs 22.5 crore, making GLS a wholly-owned subsidiary. This agreement, finalized on September 18, 2024, involves purchasing 5,90,361 equity shares at Rs 381.12 per share. Aurobindo initially acquired a 51 percent stake in GLS from Suresh ...
 "Strides Pharma secures overwhelming approval to launch OneSource, a pivotal CDMO, as it seeks final nod from NCLT for growth.")
Strides Pharma Science announced that it has received overwhelming approval from shareholders and secured creditors for the formation of OneSource, a specialty contract development and manufacturing organization (CDMO). This decision comes after meetings facilitated by the National Company Law Tribunal (NCLT). The creation of OneSource will integrate the Oral Technologies business from Strides, Sterile Injectables ...
